// App-Quantinova.ai

P586 : Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn’s disease: a multi-centre retrospective cohort study

Researchers

Presenter

  • T Townsend

Principal Investigators

  • V Razanskaite

  • S Michail

  • J Morgan

  • M Davies

  • D Storey

  • C Watters

  • D Penman

  • M Swaminathan

  • J Sabine

  • A Chapman

  • A Vyas

  • I Reilly

  • P Flanagan

  • K Bodger

  • S Subramanian

Medical Centers

  • Royal Liverpool University Hospital, Liverpool, United Kingdom

  • Aintree University Hospital, Gastroenterology, Liverpool, UK

  • Arrowe Park Hospital, Gastroenterology, Upton, UK

  • Countess of Chester Hospital, Gastroenterology, Chester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • Faecal calprotectin

Drug/Treatment

  • Entyvio

  • Ustekinumab

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved